Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study.
Erzegovesi
Stefano
S
Riboldi
Chiara
C
Di Bella
Daniela
D
Di Molfetta
Daniela
D
Mapelli
Francesca
F
Negri
Bruna
B
Tenace
Micaela
M
Bellodi
Laura
L
D000293:Adolescent; D000328:Adult; D002032:Bulimia / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins / Q000235:genetics*; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000187:drug effects / Q000235:genetics*; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016037:Single-Blind Method
D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human